Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator

This publication has 21 references indexed in Scilit:

• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
  Journal of Clinical Investigation, 1990
• Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
  Journal of the American College of Cardiology, 1990
• New approaches to treatment of myocardial infarction
  The American Journal of Cardiology, 1990
• Analysis of serial measurements in medical research.
  BMJ, 1990
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988
• Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
  Journal of Clinical Investigation, 1985
• Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis
  International Journal of Cancer, 1982
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980
• Deleterious effects due to hemorrhage after myocardial reperfusion
  The American Journal of Cardiology, 1974